![Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia | Scientific Reports Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-94438-4/MediaObjects/41598_2021_94438_Fig1_HTML.png)
Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia | Scientific Reports
![Associations of aspirin, nonsteroidal anti‐inflammatory drug and paracetamol use with PSA‐detected prostate cancer: Findings from a large, population‐based, case–control study (the ProtecT study) - Murad - 2011 - International Journal of Cancer - Associations of aspirin, nonsteroidal anti‐inflammatory drug and paracetamol use with PSA‐detected prostate cancer: Findings from a large, population‐based, case–control study (the ProtecT study) - Murad - 2011 - International Journal of Cancer -](https://onlinelibrary.wiley.com/cms/asset/996705c8-2b61-4e84-a43c-a508f95db426/ntbl003.jpg)
Associations of aspirin, nonsteroidal anti‐inflammatory drug and paracetamol use with PSA‐detected prostate cancer: Findings from a large, population‐based, case–control study (the ProtecT study) - Murad - 2011 - International Journal of Cancer -
Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0–10.0 ng/ml | PLOS ONE
![Clinical application of free/total PSA ratio in the diagnosis of prostate cancer in men over 50 years of age with total PSA levels of 2.0–25.0 ng ml-1 in Western China Gao XD, Clinical application of free/total PSA ratio in the diagnosis of prostate cancer in men over 50 years of age with total PSA levels of 2.0–25.0 ng ml-1 in Western China Gao XD,](https://ajandrology.com/articles/2022/24/2/images/AsianJAndrol_2022_24_2_195_332118_sm8.jpg)
Clinical application of free/total PSA ratio in the diagnosis of prostate cancer in men over 50 years of age with total PSA levels of 2.0–25.0 ng ml-1 in Western China Gao XD,
![Contrast-enhanced transrectal ultrasound can reduce collection of unnecessary biopsies when diagnosing prostate cancer and is predictive of biochemical recurrence following a radical prostatectomy in patients with localized prostate cancer | BMC Urology Contrast-enhanced transrectal ultrasound can reduce collection of unnecessary biopsies when diagnosing prostate cancer and is predictive of biochemical recurrence following a radical prostatectomy in patients with localized prostate cancer | BMC Urology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12894-020-00659-6/MediaObjects/12894_2020_659_Fig4_HTML.png)
Contrast-enhanced transrectal ultrasound can reduce collection of unnecessary biopsies when diagnosing prostate cancer and is predictive of biochemical recurrence following a radical prostatectomy in patients with localized prostate cancer | BMC Urology
![Kaplan-Meier Analysis of PSA Doubling Time. Freedom from biochemical... | Download Scientific Diagram Kaplan-Meier Analysis of PSA Doubling Time. Freedom from biochemical... | Download Scientific Diagram](https://www.researchgate.net/publication/247771095/figure/fig2/AS:216435726000130@1428613706360/Kaplan-Meier-Analysis-of-PSA-Doubling-Time-Freedom-from-biochemical-failure-A-freedom.png)
Kaplan-Meier Analysis of PSA Doubling Time. Freedom from biochemical... | Download Scientific Diagram
![Change in PsA-Disk score across different rheumatological variables in... | Download Scientific Diagram Change in PsA-Disk score across different rheumatological variables in... | Download Scientific Diagram](https://www.researchgate.net/publication/333111204/figure/tbl1/AS:758814324305920@1557926841247/Change-in-PsA-Disk-score-across-different-rheumatological-variables-in-patients-with-PsA.png)
Change in PsA-Disk score across different rheumatological variables in... | Download Scientific Diagram
![Frontiers | Significance of Time Until PSA Recurrence After Radical Prostatectomy Without Neo- or Adjuvant Treatment to Clinical Progression and Cancer-Related Death in High-Risk Prostate Cancer Patients Frontiers | Significance of Time Until PSA Recurrence After Radical Prostatectomy Without Neo- or Adjuvant Treatment to Clinical Progression and Cancer-Related Death in High-Risk Prostate Cancer Patients](https://www.frontiersin.org/files/MyHome%20Article%20Library/492017/492017_Thumb_400.jpg)
Frontiers | Significance of Time Until PSA Recurrence After Radical Prostatectomy Without Neo- or Adjuvant Treatment to Clinical Progression and Cancer-Related Death in High-Risk Prostate Cancer Patients
![Management of Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy: A Systematic Review of the Literature - European Urology Oncology Management of Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy: A Systematic Review of the Literature - European Urology Oncology](https://euoncology.europeanurology.com/cms/asset/01d4a800-0d15-4ea7-b280-fd90ecb935db/gr1.jpg)